Company news
Elutia, Inc. news in 2023
Elutia, Inc.'s news releases, calls and decks from 2023, newest first.
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance
December 17, 2023
Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results
November 12, 2023
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
November 8, 2023
Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
November 5, 2023
Elutia Announces Private Placement for Proceeds Up to $26 Million
September 18, 2023
Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
September 17, 2023
Calls in 2023
Decks in 2023
- Q3 2023 Earnings Presentation
Earnings · 25 slides · Nov 13, 2023